201 related articles for article (PubMed ID: 28353605)
1. Diabetes mellitus increases the risk of hepatocellular carcinoma in treatment-naïve chronic hepatitis C patients in China.
Li X; Xu H; Gao Y; Pan M; Wang L; Gao P
Medicine (Baltimore); 2017 Mar; 96(13):e6508. PubMed ID: 28353605
[TBL] [Abstract][Full Text] [Related]
2. Diabetes mellitus is a significant risk factor for the development of liver cirrhosis in chronic hepatitis C patients.
Li X; Gao Y; Xu H; Hou J; Gao P
Sci Rep; 2017 Aug; 7(1):9087. PubMed ID: 28831144
[TBL] [Abstract][Full Text] [Related]
3. The association between steatosis and diabetes with hepatocellular carcinoma in non-genotype 3 chronic hepatitis C patients.
Yen YH; Lin MT; Kuo FY; Chang KC; Tsai MC; Tseng PL; Wu CK; Lin JT; Hu TH; Lu SN; Wang JH; Hung CH; Chen CH
Liver Int; 2018 Jun; 38(6):1064-1073. PubMed ID: 29164767
[TBL] [Abstract][Full Text] [Related]
4. Association between ABO blood group and HCV-related hepatocellular carcinoma risk in China.
Li X; Xu H; Ding Z; Jin Q; Gao P
Medicine (Baltimore); 2016 Dec; 95(49):e5587. PubMed ID: 27930575
[TBL] [Abstract][Full Text] [Related]
5. Metformin and Hepatocellular Carcinoma Risk Reduction in Diabetic Patients with Chronic Hepatitis C: Fact or Fiction?
Sacco M; Ribaldone DG; Saracco GM
Viruses; 2023 Dec; 15(12):. PubMed ID: 38140692
[TBL] [Abstract][Full Text] [Related]
6. Pretreatment glucose status determines HCC development in HCV patients with mild liver disease after curative antiviral therapy.
Huang CF; Yeh ML; Huang CY; Tsai PC; Ko YM; Chen KY; Lin ZY; Chen SC; Dai CY; Chuang WL; Huang JF; Yu ML
Medicine (Baltimore); 2016 Jul; 95(27):e4157. PubMed ID: 27399135
[TBL] [Abstract][Full Text] [Related]
7. Diabetes Mellitus is a Risk Factor for Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Virus Infection in China.
Li X; Xu H; Gao P
Med Sci Monit; 2018 Sep; 24():6729-6734. PubMed ID: 30245503
[TBL] [Abstract][Full Text] [Related]
8. Type 2 diabetes and hepatocellular carcinoma: a case-control study in patients with chronic hepatitis B.
Li Q; Li WW; Yang X; Fan WB; Yu JH; Xie SS; Liu L; Ma LX; Chen SJ; Kato N
Int J Cancer; 2012 Sep; 131(5):1197-202. PubMed ID: 22052244
[TBL] [Abstract][Full Text] [Related]
9. Diabetes, hepatocellular carcinoma, and mortality in hepatitis C-infected patients: A population-based cohort study.
Huang TS; Lin CL; Lu MJ; Yeh CT; Liang KH; Sun CC; Shyu YC; Chien RN
J Gastroenterol Hepatol; 2017 Jul; 32(7):1355-1362. PubMed ID: 27930829
[TBL] [Abstract][Full Text] [Related]
10. Potential role of diabetes mellitus in the progression of cirrhosis to hepatocellular carcinoma: a cross-sectional case-control study from Chinese patients with HBV infection.
Gao C; Fang L; Zhao HC; Li JT; Yao SK
Hepatobiliary Pancreat Dis Int; 2013 Aug; 12(4):385-93. PubMed ID: 23924496
[TBL] [Abstract][Full Text] [Related]
11. A 2-year retrospective study of viral and host-associated risk factors in Pakistani hepatocellular carcinoma patients.
Ul Abideen Z; Siddique S; Nasrullah I; Khan JS; Rehman S; Tong Y; Qamar R; Butt AM
Eur J Gastroenterol Hepatol; 2019 Sep; 31(9):1103-1109. PubMed ID: 30829691
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for development of hepatocellular carcinoma in patients with chronic hepatitis C without sustained response to combination therapy.
Chang KC; Ye YH; Wu CK; Lin MT; Tsai MC; Tseng PL; Hu TH
J Formos Med Assoc; 2018 Nov; 117(11):1011-1018. PubMed ID: 29254684
[TBL] [Abstract][Full Text] [Related]
13. Increased risk of hepatocellular carcinoma in chronic hepatitis C patients with new onset diabetes: a nation-wide cohort study.
Huang YW; Wang TC; Yang SS; Lin SY; Fu SC; Hu JT; Liu CJ; Kao JH; Chen DS
Aliment Pharmacol Ther; 2015 Oct; 42(7):902-11. PubMed ID: 26211742
[TBL] [Abstract][Full Text] [Related]
14. Risk Assessment of Hepatocellular Carcinoma in Patients with Hepatitis C in China and the USA.
Parikh ND; Fu S; Rao H; Yang M; Li Y; Powell C; Wu E; Lin A; Xing B; Wei L; Lok ASF
Dig Dis Sci; 2017 Nov; 62(11):3243-3253. PubMed ID: 28948495
[TBL] [Abstract][Full Text] [Related]
15. The role of diabetes in hepatocellular carcinoma: a case-control study among United States Veterans.
El-Serag HB; Richardson PA; Everhart JE
Am J Gastroenterol; 2001 Aug; 96(8):2462-7. PubMed ID: 11513191
[TBL] [Abstract][Full Text] [Related]
16. Risk of hepatocellular carcinoma in diabetic patients and risk reduction associated with anti-diabetic therapy: a population-based cohort study.
Lai SW; Chen PC; Liao KF; Muo CH; Lin CC; Sung FC
Am J Gastroenterol; 2012 Jan; 107(1):46-52. PubMed ID: 22085817
[TBL] [Abstract][Full Text] [Related]
17. Impact of diabetes mellitus on incidence of hepatocellular carcinoma in chronic hepatitis C patients treated with interferon-based antiviral therapy.
Hung CH; Lee CM; Wang JH; Hu TH; Chen CH; Lin CY; Lu SN
Int J Cancer; 2011 May; 128(10):2344-52. PubMed ID: 20669224
[TBL] [Abstract][Full Text] [Related]
18. Diabetes Mellitus Heightens the Risk of Hepatocellular Carcinoma Except in Patients With Hepatitis C Cirrhosis.
Yang JD; Mohamed HA; Cvinar JL; Gores GJ; Roberts LR; Kim WR
Am J Gastroenterol; 2016 Nov; 111(11):1573-1580. PubMed ID: 27527741
[TBL] [Abstract][Full Text] [Related]
19. A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China.
Zhang JY; Dai M; Wang X; Lu WQ; Li DS; Zhang MX; Wang KJ; Dai LP; Han SG; Zhou YF; Zhuang H
Int J Epidemiol; 1998 Aug; 27(4):574-8. PubMed ID: 9758109
[TBL] [Abstract][Full Text] [Related]
20. Liver cirrhosis: a risk factor for gallstone disease in chronic hepatitis C patients in China.
Li X; Wang Z; Wang L; Pan M; Gao P
Medicine (Baltimore); 2017 Jun; 96(26):e7427. PubMed ID: 28658178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
